The role of CEA and CYFRA21-1 in monitoring tumor response during a first-line chemotherapy has been previously demonstrated in a publication from our Institution [8] and in a recent meta-analysis [38], but their role as predictive or treatment monitoring markers with immunotherapy has not yet been elucidated. Here, CEACAM5 is linked to neoplasm.